Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma … M Beksac, R Haznedar, T Firatli‐Tuglular, H Ozdogu, I Aydogdu, N Konuk, ... European journal of haematology 86 (1), 16-22, 2011 | 173 | 2011 |
Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic M Soy, P Atagündüz, I Atagündüz, GT Sucak Rheumatology international 41 (1), 7-18, 2021 | 141 | 2021 |
Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients P Ljungman, R de la Camara, L Perez-Bercoff, M Abecasis, ... Haematologica 96 (8), 1231, 2011 | 137 | 2011 |
Prognostic factors in critically ill cancer patients admitted to the intensive care unit G Aygencel, M Turkoglu, GT Sucak, M Benekli Journal of critical care 29 (4), 618-626, 2014 | 111 | 2014 |
Value of 18F-fluorodeoxyglucose uptake in positron emission tomography/computed tomography in predicting survival in multiple myeloma R Haznedar, SZ Akı, ÖU Akdemir, ZN Özkurt, Ö Çeneli, M Yağcı, ... European journal of nuclear medicine and molecular imaging 38, 1046-1053, 2011 | 105 | 2011 |
Tumor-associated macrophages as a prognostic parameter in multiple myeloma E Suyanı, GT Sucak, N Akyürek, S Şahin, NA Baysal, M Yağcı, ... Annals of hematology 92, 669-677, 2013 | 97 | 2013 |
The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated? GT Sucak, ZA Yegin, ZN Özkurt, ŞZ Akı, T Karakan, G Akyol Bone Marrow Transplantation 42 (7), 461-467, 2008 | 85 | 2008 |
Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working … X Cahu, M Labopin, S Giebel, M Aljurf, S Kyrcz-Krzemien, G Socie, ... Bone marrow transplantation 51 (3), 351-357, 2016 | 82 | 2016 |
Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials A Palumbo, A Waage, C Hulin, M Beksac, S Zweegman, F Gay, P Gimsing, ... haematologica 98 (1), 87, 2013 | 81 | 2013 |
Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party A Tanase, N Schmitz, H Stein, A Boumendil, H Finel, L Castagna, ... Leukemia 29 (3), 686-688, 2015 | 78 | 2015 |
Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid S Cetiner, GT Sucak, SA Kahraman, SZ Akı, B Kocakahyaoglu, ... Journal of bone and mineral metabolism 27, 435-443, 2009 | 73 | 2009 |
Acinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit: risk factors and impact on mortality M Turkoglu, E Mirza, ÖG Tunçcan, GU Erdem, M Dizbay, M Yağcı, ... Journal of critical care 26 (5), 460-467, 2011 | 72 | 2011 |
Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation ZN Ozkurt, ZA Yegin, I Yenicesu, SZ Aki, M Yagci, GT Sucak Transplantation proceedings 41 (9), 3851-3858, 2009 | 69 | 2009 |
Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload E Ozyilmaz, M Aydogdu, G Sucak, SZ Aki, ZN Ozkurt, ZA Yegin, N Kokturk Bone marrow transplantation 45 (10), 1528-1533, 2010 | 68 | 2010 |
Factors affecting stem cell mobilization for autologous hematopoietic stem cell transplantation ZN Özkurt, ZA Yeǧin, E Suyanı, ŞZ Akı, K Acar, M Yaǧcı, GT Sucak Journal of Clinical Apheresis 25 (5), 280-286, 2010 | 63 | 2010 |
Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation GT Sucak, ZA Yegin, ZN Özkurt, ŞZ Akı, M Yağci Transplantation proceedings 42 (5), 1841-1848, 2010 | 56 | 2010 |
Fibrinolytic activity in multiple myeloma M Yağcı, GT Sucak, R Haznedar American journal of hematology 74 (4), 231-237, 2003 | 49 | 2003 |
Early post-transplantation positron emission tomography in patients with Hodgkin lymphoma is an independent prognostic factor with an impact on overall survival GT Sucak, ZN Özkurt, E Suyanı, DG Yaşar, ÖÜ Akdemir, Z Akı, ZA Yeğin, ... Annals of hematology 90, 1329-1336, 2011 | 48 | 2011 |
Inspiratory muscle training in allogeneic hematopoietic stem cell transplantation recipients: a randomized controlled trial G Barğı, MB Güçlü, Z Arıbaş, ŞZ Akı, GT Sucak Supportive Care in Cancer 24, 647-659, 2016 | 47 | 2016 |
Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey A Salihoglu, T Elverdi, I Karadogan, S Paydas, E Ozdemir, G Erdem, ... Annals of hematology 94, 415-420, 2015 | 46 | 2015 |